Celularity (CELU)
NASDAQ:CELU
US Market

Celularity (CELU) Stock Price & Analysis

104 Followers

CELU Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.40 - $11.14
Previous Close$0.6
Volume331.32K
Average Volume (3M)488.46K
Market Cap
$109.06M
Enterprise Value$160.68M
Total Cash (Recent Filing)$13.97M
Total Debt (Recent Filing)$65.59M
Price to Earnings (P/E)6.0
Beta0.84
Aug 14, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.10
Shares Outstanding180,530,272
10 Day Avg. Volume840,302
30 Day Avg. Volume488,465
Standard Deviation0.18
R-Squared0.00432
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)-2.30
Price to Sales (P/S)26.47
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.94
Enterprise Value/Gross Profit-95.08
Enterprise Value/Ebitda6.30
Forecast
Price Target Upside189.69% Upside
Rating ConsensusHold
Number of Analyst Covering2


Financials

Annual

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

CELU FAQ

What was Celularity’s price range in the past 12 months?
Celularity lowest stock price was $0.40 and its highest was $11.14 in the past 12 months.
    What is Celularity’s market cap?
    Currently, no data Available
    When is Celularity’s upcoming earnings report date?
    Celularity’s upcoming earnings report date is Aug 14, 2023 which is in 78 days.
      How were Celularity’s earnings last quarter?
      Celularity released its earnings results on May 15, 2023. The company reported -$0.412 earnings per share for the quarter, missing the consensus estimate of -$0.41 by -$0.002.
        Is Celularity overvalued?
        According to Wall Street analysts Celularity’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Celularity pay dividends?
          Celularity does not currently pay dividends.
          What is Celularity’s EPS estimate?
          Celularity’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Celularity have?
          Celularity has 180,530,270 shares outstanding.
            What happened to Celularity’s price movement after its last earnings report?
            Celularity reported an EPS of -$0.412 in its last earnings report, missing expectations of -$0.41. Following the earnings report the stock price went up 10%.
              Which hedge fund is a major shareholder of Celularity?
              Currently, no hedge funds are holding shares in CELU

              ---

              Celularity Stock Smart Score

              The Celularity stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
              Learn more about TipRanks Smart Score

              Company Description

              Celularity

              GX Acquisition Corp is blank check company.

              ---

              Top 5 ETFs holding CELU

              Currently, no data available
              Please return soon. This page is being updated.
              Up to five ETFs with an Outperform Smart Score that hold CELU. The ETFs are listed according to market value of CELU within the ETF

              ---

              Forecast EPS vs Actual EPS


              Similar Stocks
              Company
              Price & Change
              Follow
              Fennec Pharmaceuticals
              Lineage Therap
              Gritstone Oncology
              Xoma

              Popular Stocks

              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis